Miltenyi Biotec

Miltenyi Biotec is a private biotechnology company founded in 1989 in Germany, specializing in cellular research, cell and gene therapy, and related technologies. Headquartered in Bergisch Gladbach, North Rhine-Westphalia, the company employs over 1,300 people across 22 countries and offers a vast range of products, with sales projected to exceed €1 billion in 2023. The company is known for pioneering MACS (Magnetic-Activated Cell Separation) technology, which has become the leading method for cell isolation. Miltenyi Biotec provides an integrated portfolio that includes solutions for sample preparation, cell separation, flow cytometry, and gene sequencing. Key products include the autoMACS Pro, MACSQuant Analyzer, and CliniMACS Cell Factories, which support automated cell and gene therapy manufacturing. The company emphasizes high-quality production through its state-of-the-art GMP facility and maintains a strong focus on advancing biomedical research and therapies for serious diseases like cancer.